journal
Journals European Journal of Medicinal ...

European Journal of Medicinal Chemistry

https://read.qxmd.com/read/38626524/novel-selective-agents-for-the-degradation-of-ar-ar-v7-to-treat-advanced-prostate-cancer
#1
JOURNAL ARTICLE
Yifei Yang, Guangyao Lv, Ruijuan Xiu, Huijie Yang, Wenyan Wang, Pengfei Yu, Jianzhao Zhang, Liang Ye, Hongbo Wang, Jingwei Tian
The androgen receptor AR antagonists, such as enzalutamide and apalutamide, are efficient therapeutics for the treatment of prostate cancer (PCa). Even though they are effective at first, resistance to both drugs occurs frequently. Resistance is mainly driven by aberrations of the AR signaling pathway including AR gene amplification and the expression of AR splice variants (e.g. AR-V7). This highlights the urgent need for alternative therapeutic strategies. Here, a total of 24 compounds were synthesized and biologically evaluated to disclose compound 20i, exhibiting potent AR antagonistic activities (IC50  = 172...
April 15, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38626522/exploration-of-isoxazole-analogs-synthesis-cox-inhibition-anticancer-screening-3d-multicellular-tumor-spheroids-and-molecular-modeling
#2
JOURNAL ARTICLE
Mohammed Hawash, Samer Abdallah, Mahmoud Abudayyak, Yarob Melhem, Mohammed Abu Shamat, Meera Aghbar, Irfan Çapan, Murad Abualhasan, Anil Kumar, Michał Kamiński, Tomasz Góral, Paulina Maria Dominiak, Shorooq Sobuh
In this study, a new series of Isoxazole-carboxamide derivatives were synthesized and characterized via HRMS, 1 H-, 13 CAPT -NMR, and MicroED. The findings revealed that nearly all of the synthesized derivatives exhibited potent inhibitory activities against both COX enzymes, with IC50 values ranging from 4.1 nM to 3.87 μM. Specifically, MYM1 demonstrated the highest efficacy among the compounds tested against the COX-1, displaying an IC50 value of 4.1 nM. The results showed that 5 compounds possess high COX-2 isozyme inhibitory effects with IC50 value in range 0...
April 15, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38615409/discovery-of-novel-amide-derivatives-as-potent-quorum-sensing-inhibitors-of-pseudomonas-aeruginosa
#3
JOURNAL ARTICLE
Zhe He, Ming-Ming Guan, Lan-Tu Xiong, Xuan Li, Yan Zeng, Xile Deng, Alastair N Herron, Zi-Ning Cui
With the increasing reports of antibiotic resistance in this species, Pseudomonas aeruginosa is a common human pathogen with important implications for public health. Bacterial quorum sensing (QS) systems are potentially broad and versatile targets for developing new antimicrobial compounds. While previous reports have demonstrated that certain amide compounds can inhibit bacterial growth, there are few reports on the specific inhibitory effects of these compounds on bacterial quorum sensing systems. In this study, thirty-one amide derivatives were synthesized...
April 13, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38631262/quantum-chemistry-calculation-aided-discovery-of-potent-small-molecule-mimics-of-glutathione-peroxidases-for-the-treatment-of-cisplatin-induced-hearing-loss
#4
JOURNAL ARTICLE
Wentao Wang, Siyu Qiu, Tianyi Zhang, Zhiwei Zheng, Kongkai Zhu, Xing Gao, Fengping Zhao, Xinyuan Ma, Hongyan Lin, Yingzi He, Canhui Zheng
Hearing loss (HL) is a health burden that seriously affects the quality of life of cancer patients receiving platinum-based chemotherapy, and few FDA-approved treatment specifically targets this condition. The main mechanisms that contribute to cisplatin-induced hearing loss are oxidative stress and subsequent cell death, including ferroptosis revealed by us as a new mechanism recently. In this study, we employed the frontier molecular orbital (FMO) theory approach as a convenient prediction method for the glutathione peroxidase (GPx)-like activity of isoselenazolones and discovered new isoselenazolones with great GPx-like activity...
April 12, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38626523/design-synthesis-and-evaluation-of-a-pyrazolo-3-4-d-pyrimidine-derivative-as-a-novel-and-potent-tgf%C3%AE-1r1-inhibitor
#5
JOURNAL ARTICLE
Yubo Wang, Yulin Liu, Yan Zhang, Zixuan Zhang, Lei Xu, Jiefu Wang, Yijie Yang, Biyu Hu, Yuhong Yao, Mingming Wei, Junfeng Wang, Bencan Tang, Kun Zhang, Shuangwei Liu, Guang Yang
The transforming growth factor β1 (TGFβ1)/SMAD signaling pathway regulates many vital physiological processes. The development of potent inhibitors targeting activin receptor-like kinase 5 (ALK5) would provide potential treatment reagents for various diseases. A significant number of ALK5 inhibitors have been discovered, and they are currently undergoing clinical evaluation at various stages. However, the clinical demands were far from being met. In this study, we utilized an alternative conformation-similarity-based virtual screening (CSVS) combined with a fragment-based drug designing (FBDD) strategy to efficiently discover a potent and active hit with a novel chemical scaffold...
April 12, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38621327/modulators-for-palmitoylation-of-proteins-and-small-molecules
#6
REVIEW
Zeshuai Fan, Yuchen Hao, Yidan Huo, Fei Cao, Longfei Li, Jianmei Xu, Yali Song, Kan Yang
As an essential form of lipid modification for maintaining vital cellular functions, palmitoylation plays an important role in in the regulation of various physiological processes, serving as a promising therapeutic target for diseases like cancer and neurological disorders. Ongoing research has revealed that palmitoylation can be categorized into three distinct types: N-palmitoylation, O-palmitoylation and S-palmitoylation. Herein this paper provides an overview of the regulatory enzymes involved in palmitoylation, including palmitoyltransferases and depalmitoylases, and discusses the currently available broad-spectrum and selective inhibitors for these enzymes...
April 12, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38615411/design-synthesis-and-biological-activity-of-d-bishomo-1%C3%AE-25-dihydroxyvitamin-d-3-analogs-and-their-crystal-structures-with-the-vitamin-d-nuclear-receptor
#7
JOURNAL ARTICLE
Adrian Fabisiak, Pawel Brzeminski, Rafal R Sicinski, Natacha Rochel, Ewa Maj, Beata Filip-Psurska, Joanna Wietrzyk, Lori A Plum, Hector F DeLuca
The biologically active metabolite of vitamin D3 - calcitriol - is a hormone involved in the regulation of calcium-phosphate homeostasis, immunological processes and cell differentiation, being therefore essential for the proper functioning of the human body. This suggests many applications of this steroid in the treatment of diseases such as rickets, psoriasis and some cancers. Unfortunately, using therapeutic doses of calcitriol is associated with high concentrations of this compound which causes hypercalcemia...
April 10, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38614062/tetrazole-derivatives-in-the-management-of-neurological-disorders-recent-advances-on-synthesis-and-pharmacological-aspects
#8
REVIEW
Shivangi Jaiswal, Kanika Verma, Jaya Dwivedi, Swapnil Sharma
Neurological disorders are the leading cause of a large number of mortalities and morbidities. Nitrogen heterocyclic compounds have been pivotal in exhibiting wide array of therapeutic applications. Among them, tetrazole is a ubiquitous class of organic heterocyclic compounds that have attracted much attention because of its unique structural and chemical properties, and a wide range of pharmacological activities comprising anti-convulsant effect, antibiotic, anti-allergic, anti-hypertensive to name a few. Owing to significant chemical and biological properties, the present review aimed at highlighting the recent advances in tetrazole derivatives with special emphasis on their role in the management of neurological diseases...
April 9, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38614061/research-progress-of-fullerenes-and-their-derivatives-in-the-field-of-pdt
#9
REVIEW
Xue Bai, Chungeng Dong, Xinle Shao, Faiz-Ur Rahman, Huifang Hao, Yongmin Zhang
In contemporary studies, the predominant utilization of C60 derivatives pertains to their role as photosensitizers or agents that scavenge free radicals. The intriguing coexistence of these divergent functionalities has prompted extensive investigation into water-soluble fullerenes. The photodynamic properties of these compounds find practical applications in DNA cleavage, antitumor interventions, and antibacterial endeavors. Consequently, photodynamic therapy is progressively emerging as a pivotal therapeutic modality within the biomedical domain, owing to its notable levels of safety and efficacy...
April 7, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38614060/quinoxaline-derivatives-recent-discoveries-and-development-strategies-towards-anticancer-agents
#10
REVIEW
Vincent Montero, Marc Montana, Manon Carré, Patrice Vanelle
Cancer is a leading cause of death and a major health problem worldwide. While many effective anticancer agents are available, most drugs currently on the market are not specific, raising issues like the common side effects of chemotherapy. However, recent research hold promises for the development of more efficient and safer anticancer drugs. Quinoxaline and its derivatives are becoming recognized as a novel class of chemotherapeutic agents with activity against different tumors. The present review compiles and discusses studies concerning the therapeutic potential of the anticancer activity of quinoxaline derivatives, covering articles published between January 2018 and January 2023...
April 7, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38608408/discovery-of-indolylacryloyl-derived-oxacins-as-novel-potential-broad-spectrum-antibacterial-candidates
#11
JOURNAL ARTICLE
Yue-Gao Hu, Narsaiah Battini, Bo Fang, Cheng-He Zhou
The emergence of serious bacterial resistance towards clinical oxacins poses a considerable threat to global public health, necessitating the development of novel structural antibacterial agents. Seven types of novel indolylacryloyl-derived oxacins (IDOs) were designed and synthesized for the first time from commercial 3,4-difluoroaniline via an eight-step procedure. The synthesized compounds were characterized by modern spectroscopic techniques. All target molecules were evaluated for antimicrobial activities...
April 7, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38588626/dual-target-inhibitors-based-on-er%C3%AE-novel-therapeutic-approaches-for-endocrine-resistant-breast-cancer
#12
REVIEW
Shuangshuang Xiong, Ke Song, Hua Xiang, Guoshun Luo
Estrogen receptor alpha (ERα), a nuclear transcription factor, is a well-validated therapeutic target for more than 70% of all breast cancers (BCs). Antagonizing ERα either by selective estrogen receptor modulators (SERMs) or selective estrogen receptor degraders (SERDs) forms the foundation of endocrine therapy and has achieved great success in the treatment of ERα positive (ERα+) BCs. Unfortunately, despite initial effectiveness, endocrine resistance eventually emerges in up to 30% of ERα+ BC patients and remains a significant medical challenge...
April 7, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38615410/8-bicycloalkyl-cpfpx-derivatives-as-potent-and-selective-tools-for-in-vivo-imaging-of-the-a-1-adenosine-receptor
#13
JOURNAL ARTICLE
Swen Humpert, Daniela Schneider, Dirk Bier, Annette Schulze, Felix Neumaier, Bernd Neumaier, Marcus Holschbach
Imaging of the A1 adenosine receptor (A1 R) by positron emission tomography (PET) with 8-cyclopentyl-3-(3-[18 F]fluoropropyl)-1-propyl-xanthine ([18 F]CPFPX) has been widely used in preclinical and clinical studies. However, this radioligand suffers from rapid peripheral metabolism and subsequent accumulation of radiometabolites in the vascular compartment. In the present work, we prepared four derivatives of CPFPX by replacement of the cyclopentyl group with norbornane moieties. These derivatives were evaluated by competition binding studies, microsomal stability assays and LC-MS analysis of microsomal metabolites...
April 6, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38614063/opportunities-and-perspectives-of-small-molecular-phosphodiesterase-inhibitors-in-neurodegenerative-diseases
#14
REVIEW
Qi Li, Qinghong Liao, Shulei Qi, He Huang, Siyu He, Weiping Lyu, Jinxin Liang, Huan Qin, Zimeng Cheng, Fan Yu, Xue Dong, Ziming Wang, Lingfei Han, Yantao Han
Phosphodiesterase (PDE) is a superfamily of enzymes that are responsible for the hydrolysis of two second messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). PDE inhibition promotes the gene transcription by activating cAMP-response element binding protein (CREB), initiating gene transcription of brain-derived neurotrophic factor (BDNF). The procedure exerts neuroprotective profile, and motor and cognitive improving efficacy. From this point of view, PDE inhibition will provide a promising therapeutic strategy for treating neurodegenerative disorders...
April 6, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38593589/ml162-derivatives-incorporating-a-naphthoquinone-unit-as-ferroptosis-apoptosis-inducers-design-synthesis-anti-cancer-activity-and-drug-resistance-reversal-evaluation
#15
JOURNAL ARTICLE
Furong Ma, Yulong Li, Maohua Cai, Wenyan Yang, Zumei Wu, Jinyun Dong, Jiang-Jiang Qin
Activating apoptosis has long been viewed as an anti-cancer process, but recently increasing evidence has accumulated that induction of ferroptosis has emerged as a promising strategy for cancer therapeutics. Glutathione peroxidase 4 (GPX4) is one of the pivotal factors regulating ferroptosis that targeted inhibition or degradation of GPX4 could effectively trigger ferroptosis. In this study, a series of ML162-quinone conjugates were constructed by using pharmacophore hybridization and bioisosterism strategies, with the aim of obtaining more active anticancer agents via the ferroptosis and apoptosis dual cell death processes...
April 6, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38604096/synthesis-and-structure-activity-optimization-of-azepane-containing-derivatives-as-ptpn2-ptpn1-inhibitors
#16
JOURNAL ARTICLE
Jiamin Zheng, Zhisen Zhang, Xiaoyu Ding, Deheng Sun, Lihua Min, Feng Wang, Sujing Shi, Xin Cai, Man Zhang, Alex Aliper, Feng Ren, Xiao Ding, Alex Zhavoronkov
Protein tyrosine phosphatases PTPN2 and PTPN1 (also known as PTP1B) have been implicated in a number of intracellular signaling pathways of immune cells. The inhibition of PTPN2 and PTPN1 has emerged as an attractive approach to sensitize T cell anti-tumor immunity. Two small molecule inhibitors have been entered the clinic. Here we report the design and development of compound 4, a novel small molecule PTPN2/N1 inhibitor demonstrating nanomolar inhibitory potency, good in vivo oral bioavailability, and robust in vivo antitumor efficacy...
April 5, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38581732/discovery-of-ganoderic-acid-a-gaa-protacs-as-mdm2-protein-degraders-for-the-treatment-of-breast-cancer
#17
JOURNAL ARTICLE
Yan Li, Guangyu Li, Chenwei Zuo, Xiaolin Wang, Fang Han, Yi Jia, Hai Shang, Yu Tian
Breast cancer is one of the most common female malignant tumors, with triple-negative breast cancer (TNBC) being the most specific, highly invasive, metastatic and associated with a poor prognosis. Our previous study showed that the natural product ganoderic acid A (GAA) has a certain affinity for MDM2. In this study, two series of novel GAA PROTACs C1-C10 and V1-V10 were designed and synthesized for the treatment of breast cancer. The antitumor activity of these compounds was evaluated against four human tumor cell lines (MCF-7, MDA-MB-231, SJSA-1, and HepG2)...
April 5, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38604095/discovery-and-optimization-of-4-pyrazolyl-2-aminopyrimidine-derivatives-as-potent-spleen-tyrosine-kinase-syk-inhibitors
#18
JOURNAL ARTICLE
Giovanni Cervi, Roberto D'Alessio, Simona Bindi, Laura Buffa, Alessia Burocchi, Giulia Canevari, Michele Modugno, Ilaria Motto, Grazia Saturno, Paolo Orsini
Spleen tyrosine kinase (Syk) is a key signal transduction mediator of the B cell receptor (BCR) signaling pathway. Abnormal BCR signaling plays a key role in initiation and development of B-cell-derived hematological malignancies, therefore, Syk represents a potential target for inhibiting the BCR signaling resulting in a therapeutic effect in these cancers. Herein, we describe a novel series of SYK inhibitors with 4-(3'-pyrazolyl)-2-amino-pyrimidine scaffold. Extensive study of structure-activity relationships led to the identification of 1 (NMS-0963), a highly potent Syk inhibitor (IC50  = 3 nM) endowed with high selectivity within a panel of tested kinases and high antiproliferative activity in SYK-dependent BaF3-TEL/SYK cells and in other BCR-dependent hematological tumor cell lines...
April 4, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38604097/discovery-of-novel-thymol-tpp-antibiotics-that-eradicate-mrsa-persisters
#19
JOURNAL ARTICLE
Ziyi Tang, Jizhou Feng, Mahesh Challa, Sankara Rao Rowthu, Shuxin Xiong, Cheng Zou, Jianguo Li, Chandra Shekhar Verma, Haibo Peng, Xiaoli He, Chao Huang, Yun He
The high prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains and the formation of non-growing, dormant "persisters" subsets help bacteria evade antibiotic treatment and enhance bacterial resistance, which poses a serious threat to human life and health. It is urgent to discover novel antibacterial therapies effective against MRSA persisters. Thymol is a common nutraceutical with weak antibacterial and antitumor activities. A series of Thymol triphenylphosphine (TPP) conjugates (TPP-Thy3) was designed and synthesized...
April 3, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38593588/active-site-directed-probes-targeting-dipeptidyl-peptidases-8-and-9
#20
JOURNAL ARTICLE
Margarida Espadinha, Joni De Loose, Sam Corthaut, Sofie Thys, Yentl Van Rymenant, Emile Verhulst, Siham Benramdane, Nicolò Filippi, Koen Augustyns, Pieter Van Wielendaele, Isabel Pintelon, Ingrid De Meester, Pieter Van der Veken
Dipeptidyl peptidases (DPP) 8 and 9 are intracellular serine proteases that play key roles in various biological processes and recent findings highlight DPP8 and DPP9 as potential therapeutic targets for hematological and inflammasome-related diseases. Despite the substantial progress, the precise biological functions of these proteases remain elusive, and the lack of selective chemical tools hampers ongoing research. In this paper, we describe the synthesis and biochemical evaluation of the first active site-directed DPP8/9 probes which are derived from DPP8/9 inhibitors developed in-house...
April 3, 2024: European Journal of Medicinal Chemistry
journal
journal
24926
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.